Dr Reddy'S LaboratoriesAktie

ISIN: US2561352038 | WKN: 659157 | Symbol: RDY
52,46
 
USD
02.06.20 NYSE
+0,40 %
+0,21 USD
Geldkurs 02.06.20
52,46 USD
3.200 Stk.
Briefkurs 02.06.20
52,52 USD
3.700 Stk.
Mehr Daten anzeigen
Smartbroker
NewsFlashAnzeige
Der sechsbeinige Cannabis-Hund schnappt zu!

Dr Reddy'S Laboratories Chart

Neuigkeiten zur Dr Reddy'S Laboratories Ltd Sponsored American Depositary Receipt Repr 1 Sh Aktie

ZeitTitel
SmartbrokerJetzt auf smartbroker.de - ab 0 € pro Order handeln! Anzeige
07.05.20

Dr. Reddy's to release Q4 and full year FY 20 results on May 20, 2020
06.05.20

Dr. Reddy's Laboratories Received Approval for Their NDA, ELYXYB (celecoxib oral solution) 25 mg/mL, in the U.S.
06.05.20

Dr. Reddy's Laboratories Announces the Launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market
27.04.20

Dr. Reddy's Laboratories Announces the Launch of Fenofibrate Tablets USP, in the U.S. Market
14.04.20

Dr. Reddy's Laboratories Announces the Launch of an Authorized Generic Version of NitroDur (nitroglycerin) Transdermal Infusion System in the U.S. Market
14.04.20

Dr. Reddy's Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market
26.03.20

Dr. Reddy's Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening
20.03.20

Dr. Reddy's Laboratories Announces the Launch of Pyrimethamine Tablets USP, 25 mg, First-Wave Generic Version of Daraprim in the U.S. Market
19.03.20

Dr. Reddy's Laboratories Announces First-to-Market Launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe in the U.S. Market
17.03.20

Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market
27.02.20

Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market
12.02.20

Dr. Reddy’s Laboratories to Acquire Select Business Divisions of Wockhardt in India
07.02.20

Dr. Reddy's Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market
12.05.16

Avatar Kalbaran schrieb:
…
29.12.11

Avatar R-BgO schrieb:
Kurs geringfügig zurückgekommen.
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Die neusten Nachrichten zu Dr Reddy'S Laboratories

ZeitTitel
07.05.20
Dr. Reddy's to release Q4 and full year FY 20 results on May 20, 2020
06.05.20
Dr. Reddy's Laboratories Received Approval for Their NDA, ELYXYB (celecoxib oral solution) 25 mg/mL, in the U.S.
06.05.20
Dr. Reddy's Laboratories Announces the Launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market
27.04.20
Dr. Reddy's Laboratories Announces the Launch of Fenofibrate Tablets USP, in the U.S. Market
14.04.20
Dr. Reddy's Laboratories Announces the Launch of an Authorized Generic Version of NitroDur (nitroglycerin) Transdermal Infusion System in the U.S. Market
mehr Dr Reddy'S Laboratories Nachrichten »

Nachrichten aus der Branche Pharmaindustrie

ZeitTitel
02:35 Uhr
North Bud Farms Provides Corporate Update
02.06.20
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
02.06.20
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02.06.20
Aktien New York Schluss: Soziale Unruhen halten die Indizes nicht auf
02.06.20
ERYTECH to Participate Fireside Chat at Jefferies Virtual Healthcare Conference
mehr Branchennachrichten »

Indexzugehörigkeit von Dr Reddy'S Laboratories

WertpapierPerf. %
NYSE Composite Index (Revised)
+2,06
DAXglobal Asia Index (Performance-Index EUR)
+3,83
ISE ChIndia Index (Net Total Return)
+4,16
ISE BICK Index (Net Total Return)
+5,10
DAX global BRIC (Net-TR) EUR (Total Return Index)
+4,91
DAXglobal BRIC-Index (Performance-Index EUR)
+4,92
DAXglobal BRIC-Index (Kurs-Index EUR)
+4,31
DBIX Deutsche Boerse India Index (Performance Index EUR)
+5,64
NYSE Arca Pharmaceutical Index (15 Drug Company Stocks & ADR's)
-0,71
STOXX Optimised India DR EUR (Price)
+2,61
Alle zugehörigen Indizes »

Aktienkurs Dr Reddy'S Laboratories 659157 |

BörsenplatzNYSE
Letzter Kurs52,46USD
Performance+0,40 %
Kurszeit02.06.20
Eröffnung52,16USD
Tageshoch52,77USD
Tagestief51,97USD
Vortageskurs52,25USD
Volumen27,62 Tsd.Stk.
52-Wochen Hoch53,72USD
52-Wochen Tief34,26USD
Anzahl Trades133
Performance 1 Monat+3,91 %
Performance 1 Jahr+43,93 %

Stammdaten zu Dr Reddy'S Laboratories

NameDr Reddy'S Laboratories Ltd
KurznameDr Reddy'S Lab
NamenszusatzShs Sponsored American Depositary Receipt Repr 1 Sh
KategorieAktien
AktientypStammaktien
WKN659157
SymbolRDY
BranchePharmaindustrie
LandIndien Indien
ReferenzwährungINR
Aktienanzahl165,77 Mio.
Marktkapitalisierung8,70 Mrd.USD

Performance Dr Reddy'S Laboratories Aktie

ZeitKursPerf.
1 Tag52,46USD
+0,40 %
1 Woche51,41USD
+3,95 %
1 Monat51,43USD
+3,91 %
3 Monate40,16USD
+33,07 %
6 Monate40,72USD
+31,24 %
Lfd. Jahr40,58USD
+31,69 %
1 Jahr37,13USD
+43,93 %
3 Jahre37,27USD
+43,39 %
5 Jahre55,43USD
-3,59 %
10 Jahre28,71USD
+86,14 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameDr Reddy'S Laboratories Ltd
StadtHyderabad
LandIndien Indien
Webseitewww.drreddys.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Enzon Pharmaceuticals
-1,39
2.
General Electric
+5,46
3.
ICICI Bank
+3,80
4.
Infosys
+0,43
5.
Morphosys
-0,87
6.
Coreo Akt
0,00
 
7.
Reliance Industries
+2,27
8.
STRATEC
-0,54
9.
Wipro
+0,59
10.
Ballard Power Systems
-0,73

Handelsinformationen

Handelszeit09:30 - 16:00 Uhr
Liquidister HandelsplatzNYSE